Skip to main content

Published locations for First-line ibrutinib an effective treatment for patients with CLL carrying TP53 aberrations

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First-line ibrutinib an effective treatment for patients with CLL carrying TP53 aberrations

User login

  • Reset your password
  • /content/first-line-ibrutinib-effective-treatment-patients-cll-carrying-tp53-aberrations
  • /b-cell-lymphoma-icymi/article/264263/b-cell-lymphoma/first-line-ibrutinib-effective-treatment